InVivium Capital
Venture capitalChicago · Seed–Late Stage · 6 people tracked
Also known as INVIVIUM CAPITAL MANAGEMENT, LLC
Find your way into InVivium Capital
945 people in our graph share verified history with the InVivium Capital team — schools, employers, funds. One of them is your warm intro.
Investment thesis
InVivium Capital invests in transformative life sciences and healthcare innovation. The firm believes the healthcare industry is undergoing dramatic change that creates significant opportunity for groundbreaking innovation to meaningfully improve lives, health, and the quality of care people receive. Its stated mission is to work closely alongside exceptional founders and teams to bring transformational technologies to life.
Source: firm website, verified Sep 15, 2026.
Team · 6 people
from the firm's website
What they invest in
from 6 of 9 portfolio companiesBiotech ×6Healthtech ×3AI & Machine Learning ×1Deep Tech ×1Digital Health ×1Medical Devices ×1Mental Health ×1Robotics ×1
HQs:United States×6
Investments · 9 tracked
founders shown can be your intro pathBy year:2024 · 12023 · 12021 · 12020 · 14 dated
Alto Neuroscience is a clinical-stage biopharmaceutical company developing biology-driven medicines for neuropsychiatric conditions, using measurements of brain biology to predict clinical response and identify patients likely to benefit from its drug candidates.
BiotechDigital HealthMental HealthMountain View, US
Amit Etkin(Founder)inAdam Savitz(Executive Officer)inNicholas C. Smith(Executive Officer)inMichael Hanley(Executive Officer)Nicholas Smith(Chief Financial Officer and Chief Business Officer)inAaron Weaver(Director)
Board seatMichael Liang· per SEC Form D
Co-investorsAble PartnersAlpha Wave GlobalK2 HealthVenturesKorify CapitalVivo CapitalWhat If Ventures+4 more
Avalyn Pharma develops inhaled therapies for pulmonary fibrosis, using a nebulization approach that delivers treatment directly to the lungs to reduce the tolerability problems of existing oral therapies.
BiotechHealthtech
Lyn Baranowski(CEO)in
Co-investorsAndera PartnersCatalio Capital Management, LPF-Prime CapitalNorwest Venture PartnersRiverVest Venture PartnersSR One Capital Management+9 more
Grove Biopharma develops Bionic Biologics, a drug discovery platform combining AI-enabled molecular design, precision polymer chemistry, and experimental biology to target protein-protein interactions that are inaccessible to conventional therapeutics.
AI & Machine LearningBiotechDeep TechChicago, US
Geoffrey Duyk(CEO)inGeoffrey M. Duyk, M.D., Ph.D.(Chief Executive Officer)in
Co-investorsDCVC (Data Collective)DCVC BioPortal Innovations
Hinge Bio is a biotechnology company developing next-generation therapeutics based on its GEM-DIMER platform, aimed at improving efficacy and reducing resistance and side effects.
BiotechHealthtechBurlingame, US
Daniel J. Capon(Director)Carin Mueller Rollins(Co-Founder & Chief Operating Officer)Harold E. Selick, PhD(Executive Officer, Director)Miriam Siekevitz(Executive Officer)inHarold E. "Barry" Selick(Chief Executive Officer & Director)Paul Brunetta(Chief Medical Officer)in
Co-investorsPoint72Agent CapitalBaruch Future VenturesRidgeback Capital
Onchilles Pharma is a biopharmaceutical company developing novel therapeutics based on scientific research to address unmet medical needs.
BiotechSan Diego, US
Lev Becker, Ph.D.(Director)Marc Nasoff(Chief Development Officer)Court Turner(Executive Officer, Director)Kevin Li, Ph.D.(Director)
Virtual Incision develops a miniaturized robotic-assisted surgery (miniRAS) system called MIRA, designed to fit within hospitals' existing infrastructure.
BiotechHealthtechMedical DevicesRoboticsLincoln, US
Dmitry Oleynikov(Director)Shane Farritor(Executive Officer, Director)John P. Murphy(Executive Officer, Director)inMukund Srinivasan(Executive Officer)in
BoardTom Shehab(Director)Fred Robertson(Director)
Co-investorsArboretum VenturesEndeavour VisionInvest NebraskaBaird CapitalPrairieGold Venture Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
CALA HEALTH, INC.555 Bryant StreetRevelyx Bio
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 2
2 IPOsAlto NeuroscienceNYSE: ANROAvalyn Pharma IncNASDAQ: AVLN
Portfolio news
latest coverage across their companies
Alto Neuroscience · finance.yahoo.com · Aug 16, 2026
Virtual Incision · beatricedailysun.com · May 18, 2026
Avalyn Pharma Inc · investing.com · May 1, 2026
Grove Biopharma · xtalks.com · Jan 8, 2026
Onchilles Pharma · hitconsultant.net · Nov 7, 2025
Frequently asked questions
- How many investments has InVivium Capital made?
- InVivium Capital has 9 tracked investments, 2 of which have exited, including 1 dated in the last 24 months.
- What stage does InVivium Capital invest at?
- InVivium Capital invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does InVivium Capital focus on?
- InVivium Capital focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is InVivium Capital located?
- InVivium Capital is headquartered in Chicago, US.
- Who does InVivium Capital co-invest with?
- InVivium Capital most often shares deals with Arboretum Ventures, DCVC (Data Collective), F-Prime Capital, among 21 tracked co-investors.
Similar investors
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
Lumira Ventures is a North American life sciences venture capital firm that partners with mission-driven entrepreneurs to build companies developing and commercializing healthcare products for patients.
Gore Range Capital is a specialized healthcare investment firm building science-led platforms across precision health, regenerative medicine, personalized therapeutics, and longevity. It provides strategic, financial, and clinical guidance to portfolio companies developing next-generation healthcare solutions.